Page last updated: 2024-09-02

7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Alloxan Diabetes

7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, YJ; Kim, WB; Kwon, JW; Lee, HJ; Lee, MG; Yang, J1

Other Studies

1 other study(ies) available for 7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Alloxan Diabetes

ArticleYear
Pharmacokinetic changes of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus rats.
    Research communications in molecular pathology and pharmacology, 1996, Volume: 94, Issue:2

    Topics: Alloxan; Animals; Antibiotics, Antineoplastic; Area Under Curve; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Doxorubicin; Half-Life; Kidney; Liver; Organ Size; Rats; Rats, Sprague-Dawley; Tissue Distribution

1996